The enriched MDK–NCL signal could serve as a sign of CAF activation to stimulate downstream pathways for promoting tumour invasion, and therefore may be a potential early biomarker of ESCC progression. This evidence concerns the gene NUCLEOLIN and esophageal squamous cell carcinoma.